The Artemis Podcast

Thomas McCann, MD

A radiologist who injects walks through aesthetic medicine with the evidence. Dr. Tom McCann, a board-certified radiologist and the physician at Artemis Modern Aesthetics in Medford, New Jersey, and Alexandra cover neuromodulators, fillers, GLP-1 medicines, skin science and devices, one primary source at a time. The voices in this show are generated with AI using ElevenLabs. Tom writes and reviews every script, and the sources are in the show notes.

  1. 1d ago

    LightFrame™: The Shadow Isn't the Problem

    What people notice in a face is light and shadow, not millimeters. Dr. Tom McCann, a board-certified diagnostic radiologist, and Nova, his AI co-host, walk through LightFrame™, the consultation method Tom built at Artemis Modern Aesthetics. They cover why the same under-eye shadow can need opposite plans, the five layers LightFrame reads (Frame, Support, Volume, Surface and Light), why it avoids the golden-ratio mask, what happens in the hour-long consult, when ultrasound is used, what you leave with, what it costs, and what the method does not claim.Key facts. In photo overlays spanning 10 to 50 years, the lid-cheek junction barely moved; it became more visible through contrast and shadow (Lambros 2007). Facial contrast falls with age, and lower-contrast faces are judged older (Porcheron 2013, authors from a skin research center funded by a cosmetics company). CT studies show the orbits enlarge, midface angles flatten and the mandible shortens with age (Shaw 2011). Facial fat sits in separate compartments that age differently (Rohrich and Pessa 2007). The golden-ratio Phi mask has been criticized for fitting many faces poorly (Holland 2008). Ultrasound can often show where old filler sits (Schelke 2010).The LightFrame™ consult is $250, credited in full toward treatment booked within 30 days. Every consult and treatment is done by Dr. McCann. LightFrame™ is a consultation and planning method, not a validated scoring test, and it cannot promise a result.Disclosure. LightFrame™ is Tom's own method and trademark, and the consult is a paid service at Artemis. This episode is about something he sells. No outside company paid for it.For patients: text the Artemis office at (833) 387-2996 or leave your info on the Artemis Modern Aesthetics website for a callback. Read more at mccannmd.com/lightframe. For clinicians: courses and imaging teaching at mccannmd.com.Join the waitlist for the aesthetic ultrasound injector course: https://artemis-modern-aesthetics.kit.com/dae19ec596The voices in this episode were generated with AI using ElevenLabs. Tom reviews every script.This episode is education, not medical advice for any individual.References1. Lambros V. Observations on periorbital and midface aging. Plast Reconstr Surg. 2007;120(5):1367-1376. https://doi.org/10.1097/01.prs.0000279348.09156.c32. Porcheron A, Mauger E, Russell R. Aspects of facial contrast decrease with age and are cues for age perception. PLoS One. 2013;8(3):e57985. https://doi.org/10.1371/journal.pone.00579853. Shaw RB Jr, Katzel EB, Koltz PF, et al. Aging of the facial skeleton: aesthetic implications and rejuvenation strategies. Plast Reconstr Surg. 2011;127(1):374-383. https://doi.org/10.1097/PRS.0b013e3181f95b2d4. Rohrich RJ, Pessa JE. The fat compartments of the face: anatomy and clinical implications for cosmetic surgery. Plast Reconstr Surg. 2007;119(7):2219-2227. https://doi.org/10.1097/01.prs.0000265403.66886.545. Holland E. Marquardt's Phi mask: pitfalls of relying on fashion models and the golden ratio to describe a beautiful face. Aesthetic Plast Surg. 2008;32(2):200-208. https://doi.org/10.1007/s00266-007-9080-z6. Schelke LW, Van Den Elzen HJ, Erkamp PP, Neumann HA. Use of ultrasound to provide overall information on facial fillers and surrounding tissue. Dermatol Surg. 2010;36 Suppl 3:1843-1851. https://doi.org/10.1111/j.1524-4725.2010.01740.x

  2. 2d ago

    The Drugstore Aisle: What Actually Works

    One of our technologists asked what in the drugstore skincare aisle is actually supported by evidence. Dr. Tom McCann and Nova, his AI co-host, grade the common ingredients into strong, moderate and weak tiers, explain what niacinamide, vitamin C, alpha hydroxy acids, azelaic acid, hyaluronic acid, ceramides, peptides, growth factors and collagen supplements have and haven't shown, and take apart label claims like dermatologist recommended, hypoallergenic and boosts collagen.Key facts. Topical 5% niacinamide improved fine lines, red blotchiness, spots and sallowness in 50 women over 12 weeks (Bissett 2005, manufacturer-run). Oral nicotinamide 500 mg twice daily lowered new non-melanoma skin cancers by 23% in 386 high-risk patients (ONTRAC, NEJM 2015). 8% glycolic or lactic acid improved photodamage in 76% and 71% of women vs 40% on vehicle (Stiller 1996). 20% azelaic acid matched 4% hydroquinone for melasma in 329 women (1991). Cochrane 2017 (77 trials): moisturizers reduce eczema flares, no moisturizer shown better than another. BEEP 2020 (1,394 infants): daily emollient did not prevent eczema. Collagen supplements: no benefit in non-industry-funded or high-quality trials (Am J Med 2025, 23 RCTs). Of 174 best-selling moisturizers, 12% were free of common allergens; 45% of fragrance-free products had a fragrance cross-reactor or botanical (JAMA Dermatol 2017).Disclosure. No brands are named, nobody paid for this episode, and industry-funded studies are identified as such. Tom's practice, Artemis Modern Aesthetics, sells skincare in the office.For clinicians: courses, the Complication and Emergency Protocol Pack, and imaging teaching at mccannmd.com. For patients: text the Artemis office at (833) 387-2996 or leave your info on the Artemis Modern Aesthetics website for a callback.Join the waitlist for the aesthetic ultrasound injector course: https://artemis-modern-aesthetics.kit.com/dae19ec596The voices in this episode were generated with AI using ElevenLabs. Tom reviews every script.This episode is education, not medical advice for any individual.References1. Hughes MCB, Williams GM, Baker P, Green AC. Sunscreen and prevention of skin aging: a randomized trial. Ann Intern Med. 2013;158(11):781-790. https://doi.org/10.7326/0003-4819-158-11-201306040-000022. Bissett DL, Oblong JE, Berge CA. Niacinamide: a B vitamin that improves aging facial skin appearance. Dermatol Surg. 2005;31(7 Pt 2):860-865. https://doi.org/10.1111/j.1524-4725.2005.317323. Chen AC, Martin AJ, Choy B, et al. A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. N Engl J Med. 2015;373(17):1618-1626. https://doi.org/10.1056/NEJMoa15061974. Humbert PG, Haftek M, Creidi P, et al. Topical ascorbic acid on photoaged skin: clinical, topographical and ultrastructural evaluation. Exp Dermatol. 2003;12(3):237-244. https://doi.org/10.1034/j.1600-0625.2003.00008.x5. Stiller MJ, Bartolone J, Stern R, et al. Topical 8% glycolic acid and 8% L-lactic acid creams for the treatment of photodamaged skin. Arch Dermatol. 1996;132(6):631-636. PMID 8651713. https://pubmed.ncbi.nlm.nih.gov/8651713/6. Balina LM, Graupe K. The treatment of melasma: 20% azelaic acid versus 4% hydroquinone cream. Int J Dermatol. 1991;30(12):893-895. https://doi.org/10.1111/j.1365-4362.1991.tb04362.x7. Reynolds RV, Yeung H, Cheng CE, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024;90(5):1006.e1-1006.e30. https://doi.org/10.1016/j.jaad.2023.12.0178. Pavicic T, Gauglitz GG, Lersch P, et al. Efficacy of cream-based novel formulations of hyaluronic acid of different molecular weights in anti-wrinkle treatment. J Drugs Dermatol. 2011;10(9):990-1000. PMID 22052267. https://pubmed.ncbi.nlm.nih.gov/22052267/9. van Zuuren EJ, Fedorowicz Z, Christensen R, Lavrijsen A, Arents BWM. Emollients and moisturisers for eczema. Cochrane Database Syst Rev. 2017;2:CD012119. https://doi.org/10.1002/14651858.CD012119.pub210. Chalmers JR, Haines RH, Bradshaw LE, et al. Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial. Lancet. 2020;395(10228):962-972. https://doi.org/10.1016/S0140-6736(19)32984-811. Robinson LR, Fitzgerald NC, Doughty DG, et al. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci. 2005;27(3):155-160. https://doi.org/10.1111/j.1467-2494.2005.00261.x12. Abud B, McGinn L, Cawthon E, et al. A randomized, double-blinded pilot study comparing synthetic versus human-derived topical epidermal growth factor for facial rejuvenation. J Cosmet Dermatol. 2026;25(5):e70927. https://doi.org/10.1111/jocd.7092713. Myung SK, Park Y. Effects of collagen supplements on skin aging: a systematic review and meta-analysis of randomized controlled trials. Am J Med. 2025;138(9):1264-1277. https://doi.org/10.1016/j.amjmed.2025.04.03414. Xu S, Kwa M, Lohman ME, Evers-Meltzer R, Silverberg JI. Consumer preferences, product characteristics, and potentially allergenic ingredients in best-selling moisturizers. JAMA Dermatol. 2017;153(11):1099-1105. https://doi.org/10.1001/jamadermatol.2017.304615. US Food and Drug Administration. Alpha hydroxy acids (content current as of November 22, 2022). https://www.fda.gov/cosmetics/cosmetic-ingredients/alpha-hydroxy-acids16. US Food and Drug Administration. FDA works to protect consumers from potentially harmful OTC skin lightening products, April 19, 2022. https://www.fda.gov/drugs/drug-safety-and-availability/fda-works-protect-consumers-potentially-harmful-otc-skin-lightening-products17. US Food and Drug Administration. Hypoallergenic cosmetics. https://www.fda.gov/cosmetics/cosmetics-labeling-claims/hypoallergenic-cosmetics18. US Food and Drug Administration. Wrinkle treatments and other anti-aging products. https://www.fda.gov/cosmetics/products/wrinkle-treatments-and-other-anti-aging-products19. US Food and Drug Administration. FDA expands sunscreen options for the first time in 20 years, June 9, 2026. https://www.fda.gov/news-events/press-announcements/fda-expands-sunscreen-options-first-time-20-years20. US Food and Drug Administration. Limited number of voluntary recalls initiated after FDA testing of acne products for benzene, March 11, 2025. https://www.fda.gov/drugs/drug-safety-and-availability/limited-number-voluntary-recalls-initiated-after-fda-testing-acne-products-benzene-findings-show

  3. 2d ago

    Scan Everything? A Radiologist on Whole-Body MRI

    Whole-body MRI is getting cheaper and easier to book. Dr. Tom McCann, a board-certified diagnostic radiologist who reads whole-body screening MRIs, and Nova, his AI co-host, go through the latest news: a nationwide rollout of whole-body MRI packages and a company-funded model claiming the scans can pay for themselves for employers. They cover what the scan does and doesn't see, what the American College of Radiology, a 2026 AJR expert panel and a new Cochrane protocol say about the evidence, how often healthy people get a finding that needs more testing, and five questions to ask before you book.Key facts. Fitnescity Health is offering non-contrast whole-body MRI at nearly 100 US locations, $995 to $2,995, and says it does not replace mammography or colorectal screening (AuntMinnie, Nov 10, 2026). A Prenuvo-released model of a hypothetical 100,000-worker employer estimated about 41 cents recovered per dollar when everyone was scanned once and $1.22 in a higher-risk group aged 50 and over (Nov 12, 2026). ACR: insufficient evidence to recommend total body MRI screening in people without symptoms or risk factors (2023). In 12 studies of 5,373 people without symptoms, 32.1% had a critical or indeterminate finding and about 16% of findings were false positives (JMRI 2019). Cochrane began a formal review of whole-body MRI and CT screening in 2026; results are not yet published.For patients: text the Artemis office at (833) 387-2996 or leave your info on the Artemis Modern Aesthetics website for a callback. For clinicians: courses and imaging teaching at mccannmd.com.Join the waitlist for the aesthetic ultrasound injector course: https://artemis-modern-aesthetics.kit.com/dae19ec596The voices in this episode were generated with AI using ElevenLabs. Tom reviews every script.This episode is education, not medical advice for any individual.References1. AuntMinnie.com staff. Fitnescity Health adds whole-body MRI to preventive imaging network. November 10, 2026. https://www.auntminnie.com/clinical-news/mri/news/16425072/fitnescity-health-adds-wholebody-mri-to-preventive-imaging-network2. Prenuvo (PR Newswire). New Prenuvo research finds whole-body MRI screening could pay for itself for employers. November 12, 2026. https://www.prnewswire.com/news-releases/new-prenuvo-research-finds-whole-body-mri-screening-could-pay-for-itself-for-employers-302937066.html3. American College of Radiology. ACR statement on screening total body MRI. April 17, 2023. https://www.acr.org/News-and-Publications/Media-Center/2023/ACR-Statement-on-Screening-Total-Body-MRI4. Petralia G, Akin O, Brookmeyer C, et al. Whole-body MRI in asymptomatic individuals: promise and perils. Expert panel review. AJR Am J Roentgenol. Published online September 23, 2026. https://doi.org/10.2214/AJR.26.354205. Chen Z, Johansson M, Albarqouni L, Woloshin S, Jørgensen KJ. Whole-body MRI or CT screening for reducing morbidity and mortality from multiple diseases in asymptomatic adults (protocol). Cochrane Database Syst Rev. 2026;8:CD016234. https://doi.org/10.1002/14651858.CD0162346. Lee J, Cyphers E, Beutler BD. Brief communication: the clinical opportunities and ongoing challenges with whole-body MRI for screening. Clin Imaging. 2026;138:110907. https://doi.org/10.1016/j.clinimag.2026.1109077. Kwee RM, Kwee TC. Whole-body MRI for preventive health screening: a systematic review of the literature. J Magn Reson Imaging. 2019;50(5):1489-1503. https://doi.org/10.1002/jmri.267368. Umipig K. Prenuvo opens its 200K MRI scans to researchers. Longevity.Technology, October 16, 2026. https://longevity.technology/news/prenuvo-opens-its-200k-mri-scans-to-researchers/9. Madden Yee K. Road to RSNA 2026: MRI preview. AuntMinnie.com, November 12, 2026. https://www.auntminnie.com/resources/conference/rsna/2026/mri-preview/article/16425347/road-to-rsna-2026-mri-preview

  4. 2d ago

    Is Your Phone Aging Your Face? Screens, Sunlight and the Scans You Get

    Is your phone aging your skin? Dr. Tom McCann, a board-certified diagnostic radiologist, and Nova, his AI co-host, compare three kinds of light: sunlight, the blue light from screens, and the radiation from medical imaging. They cover what blue light is, why the sun delivers far more of it than any device, what a 2022 systematic review found about screens and skin, why visible light matters for pigment in darker skin and melasma, what iron oxide in tinted sunscreen does, what SPF and broad spectrum do and don't cover, and why routine X-rays and CT scans are nowhere near the doses that affect skin.Key facts. Blue light is about 25% of the sun's rays and about 30% of what electronic devices emit, but the sun is the main source of effective exposure for pigmentation and oxidative stress (J Photochem Photobiol B 2022). Of 87 articles on device blue light and skin, 9 met inclusion criteria; device blue light was not identified as a hazard for pigmentation, redness, yellowness or melasma, and was not classified as a photoaging hazard, with low confidence (Photochem Photobiol Sci 2022). Visible light caused darker, longer-lasting pigmentation than UVA1 in skin types IV to VI and none in type II (J Invest Dermatol 2010). In 68 melasma patients on hydroquinone, iron oxide sunscreen gave 15% greater improvement in MASI and 28% in colorimetry than UV-only sunscreen at 8 weeks (Photodermatol Photoimmunol Photomed 2014). Noticeable skin changes after a single procedure appear about a month after a peak skin dose above several gray (Radiology 2010). US average natural background radiation is about 3 mSv a year; a chest X-ray is about 10 days of it, a dental X-ray about 1 day, screening digital mammography about 34 days, a brain CT about 7 months (RadiologyInfo.org).For patients: text the Artemis office at (833) 387-2996 or leave your info on the Artemis Modern Aesthetics website for a callback. For clinicians: courses and imaging teaching at mccannmd.com.Join the waitlist for the aesthetic ultrasound injector course: https://artemis-modern-aesthetics.kit.com/dae19ec596The voices in this episode were generated with AI using ElevenLabs. Tom reviews every script.This episode is education, not medical advice for any individual.References1. de Gálvez EN, Aguilera J, Solis A, et al. The potential role of UV and blue light from the sun, artificial lighting, and electronic devices in melanogenesis and oxidative stress. J Photochem Photobiol B. 2022;228:112405. https://doi.org/10.1016/j.jphotobiol.2022.1124052. Ceresnie MS, Patel J, Lim HW, Kohli I. The cutaneous effects of blue light from electronic devices: a systematic review with health hazard identification. Photochem Photobiol Sci. Published online 2022; 2023;22(2):457-464. https://doi.org/10.1007/s43630-022-00318-93. Duteil L, Queille-Roussel C, Lacour JP, Montaudié H, Passeron T. Short-term exposure to blue light emitted by electronic devices does not worsen melasma. J Am Acad Dermatol. 2020;83(3):913-914. https://doi.org/10.1016/j.jaad.2019.12.0474. Mahmoud BH, Ruvolo E, Hexsel CL, et al. Impact of long-wavelength UVA and visible light on melanocompetent skin. J Invest Dermatol. 2010;130(8):2092-2097. https://doi.org/10.1038/jid.2010.955. Castanedo-Cazares JP, Hernandez-Blanco D, Carlos-Ortega B, Fuentes-Ahumada C, Torres-Álvarez B. Near-visible light and UV photoprotection in the treatment of melasma: a double-blind randomized trial. Photodermatol Photoimmunol Photomed. 2014;30(1):35-42. https://doi.org/10.1111/phpp.120866. Boukari F, Jourdan E, Fontas E, et al. Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: a prospective randomized comparative trial. J Am Acad Dermatol. 2015;72(1):189-190.e1. https://doi.org/10.1016/j.jaad.2014.08.0237. Polena H, Queille-Roussel C, Graizeau C, Duteil L, Sayag M, Passeron T. Comparison of visible light-protective tinted sunscreen to untinted sunscreen to protect melasma patients during summer: a prospective randomized investigator-blinded study. J Cosmet Dermatol. 2025;24(10):e70450. https://doi.org/10.1111/jocd.704508. US Food and Drug Administration. Sunscreen: how to help protect your skin from the sun (content current as of October 16, 2026). https://www.fda.gov/drugs/understanding-over-counter-medicines/sunscreen-how-help-protect-your-skin-sun9. Balter S, Hopewell JW, Miller DL, Wagner LK, Zelefsky MJ. Fluoroscopically guided interventional procedures: a review of radiation effects on patients' skin and hair. Radiology. 2010;254(2):326-341. https://doi.org/10.1148/radiol.254208231210. RadiologyInfo.org (American College of Radiology and Radiological Society of North America). Radiation dose (reviewed April 15, 2025). https://www.radiologyinfo.org/en/info/safety-xray11. Hughes MCB, Williams GM, Baker P, Green AC. Sunscreen and prevention of skin aging: a randomized trial. Ann Intern Med. 2013;158(11):781-790. https://doi.org/10.7326/0003-4819-158-11-201306040-00002

  5. 2d ago

    Botox at 22: Prevention or Sales Pitch?

    Twenty-somethings are booking toxin to prevent wrinkles. Dr. Tom McCann and Nova, his AI co-host, look at how common it really is, the theory behind prejuvenation, the identical-twin case report it rests on, what a 2025 computer model found, the downsides of starting early, what the label covers, why screening for body dysmorphic disorder matters, and the prevention with the best evidence.Key facts. ISAPS survey as reported by ABC News: 20.5 million nonsurgical procedures worldwide in 2024, up 44% from 2020. ASPS 2024: 9,883,711 neuromodulator procedures by member surgeons, 142,907 in patients aged 20 to 29. TikTok prejuvenation study: 303 videos, more than 61 million views, 84.8% posted by nonphysicians (Rothchild 2024). Identical twins: no imprinted forehead or glabellar lines in the twin treated 2 to 3 times a year for 13 years (Binder 2006; 19-year follow-up, Rivkin 2015). Computer model: no sustained structural difference at 15 years by start age or frequency (Rahman 2025, in silico). Toxin-related muscle atrophy is temporary and reversible (Durand 2016). Neutralizing antibodies in 3 of 810 glabellar trial subjects (pooled analysis, Toxins 2023). BOTOX Cosmetic label: adults, moderate to severe lines; glabellar trials enrolled ages 18 to 75, mean 46; safety and effectiveness not established in pediatric patients. Body dysmorphic disorder: 15.04% of plastic surgery and 12.65% of dermatology patients (Ribeiro 2017). Daily sunscreen: no detectable increase in skin aging over 4.5 years, 24% less aging than discretionary use (Hughes 2013).For clinicians: courses, the Complication and Emergency Protocol Pack, and imaging teaching at mccannmd.com. For patients: text the Artemis office at (833) 387-2996 or leave your info on the Artemis Modern Aesthetics website for a callback.Join the waitlist for the aesthetic ultrasound injector course: https://artemis-modern-aesthetics.kit.com/dae19ec596The voices in this episode were generated with AI using ElevenLabs. Tom reviews every script.This episode is education, not medical advice for any individual.References1. Medhora S. Why more Gen Zs are getting cosmetic injectables such as Botox. ABC News (Australia), February 28, 2026. https://www.abc.net.au/news/2026-02-28/gen-z-driving-boost-cosmetic-injectables/1062586462. American Society of Plastic Surgeons. 2024 Procedural Statistics: Cosmetic procedures, ages 20 to 29. https://www.plasticsurgery.org/documents/news/statistics/2024/cosmetic-procedures-ages-20-29-2024.pdf3. American Society of Plastic Surgeons. 2024 Plastic Surgery Statistics Report. https://www.plasticsurgery.org/documents/news/statistics/2024/plastic-surgery-statistics-report-2024.pdf4. Rothchild E, Jung G, Wang F, Ricci JA. Prejuvenation: what social media tells us about the rising trend. Aesthet Surg J. 2024;44(4):436-443. https://doi.org/10.1093/asj/sjad3475. Binder WJ. Long-term effects of botulinum toxin type A (Botox) on facial lines: a comparison in identical twins. Arch Facial Plast Surg. 2006;8(6):426-431. https://doi.org/10.1001/archfaci.8.6.4266. Rivkin A, Binder WJ. Long-term effects of onabotulinumtoxinA on facial lines: a 19-year experience of identical twins. Dermatol Surg. 2015;41 Suppl 1:S64-S66. https://doi.org/10.1097/DSS.00000000000001937. Rahman E, Webb WR, Michon A, et al. A 15-year computational twin modeling study of botulinum toxin A frequency and age-related facial aging. Aesthetic Plast Surg. 2026;50(7):2696-2713. https://doi.org/10.1007/s00266-025-05497-18. Durand PD, Couto RA, Isakov R, et al. Botulinum toxin and muscle atrophy: a wanted or unwanted effect. Aesthet Surg J. 2016;36(4):482-487. https://doi.org/10.1093/asj/sjv2089. Pooled immunogenicity analysis of onabotulinumtoxinA across 33 clinical trials (AbbVie authors). Toxins, 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10224273/10. BOTOX Cosmetic (onabotulinumtoxinA) prescribing information, revised 10/2024, sections 1, 8.4 and 14.1. https://www.rxabbvie.com/pdf/botox-cosmetic_pi.pdf11. Ribeiro RVE. Prevalence of body dysmorphic disorder in plastic surgery and dermatology patients: a systematic review with meta-analysis. Aesthetic Plast Surg. 2017;41(4):964-970. https://doi.org/10.1007/s00266-017-0869-012. Adler R, Feig JL, Grant-Kels JM. A wrinkle in time: ethical questions in prejuvenation. J Am Acad Dermatol. 2026 (letter, published online September 7, 2026). https://doi.org/10.1016/j.jaad.2026.08.11813. Hughes MC, Williams GM, Baker P, Green AC. Sunscreen and prevention of skin aging: a randomized trial. Ann Intern Med. 2013;158(11):781-790. https://doi.org/10.7326/0003-4819-158-11-201306040-00002

  6. 2d ago

    Retinoids Untangled: Retinol, Adapalene and Tretinoin

    Retinol, retinal, adapalene and tretinoin are one family, but they are not interchangeable. Dr. Tom McCann and Nova, his AI co-host, explain the conversion ladder from retinyl esters to retinoic acid, how much strength is lost at each step, what the trials show for acne versus photoaging, how over-the-counter adapalene compares with prescription tretinoin, how to start without irritation, and what to know about pregnancy.Key facts. Retinyl esters convert to retinol, then retinal (retinaldehyde), then retinoic acid (tretinoin). About 0.25% retinol produced cellular changes similar to 0.025% retinoic acid without redness (Duell 1997). 0.4% retinol reduced fine wrinkles in subjects with a mean age of 87 (Kafi 2007). 0.05% retinaldehyde reduced wrinkles comparably to 0.05% tretinoin at 18 weeks, with less irritation (Creidi 1998). 0.05% tretinoin improved photodamage in 79% vs 48% on vehicle (251 subjects, Weinstein 1991). Adapalene 0.1% gel matched tretinoin 0.025% gel for acne with better tolerability (meta-analysis, 900 patients). Adapalene 0.3% gel was non-inferior to tretinoin 0.05% cream for photoaging (Bagatin 2018). First-trimester topical tretinoin was not associated with increased birth defects in 106 exposed pregnancies (Loureiro 2005).For clinicians: courses, the Complication and Emergency Protocol Pack, and imaging teaching at mccannmd.com. For patients: text the Artemis office at (833) 387-2996 or leave your info on the Artemis Modern Aesthetics website for a callback.Join the waitlist for the aesthetic ultrasound injector course: https://artemis-modern-aesthetics.kit.com/dae19ec596The voices in this episode were generated with AI using ElevenLabs. Tom reviews every script.This episode is education, not medical advice for any individual.References1. Duell EA, Kang S, Voorhees JJ. Unoccluded retinol penetrates human skin in vivo more effectively than unoccluded retinyl palmitate or retinoic acid. J Invest Dermatol. 1997;109(3):301-305. https://doi.org/10.1111/1523-1747.ep123357882. Mukherjee S, Date A, Patravale V, et al. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging. 2006;1(4):327-348. https://doi.org/10.2147/ciia.2006.1.4.3273. Weiss JS, Ellis CN, Headington JT, et al. Topical tretinoin improves photoaged skin: a double-blind vehicle-controlled study. JAMA. 1988;259(4):527-532. PMID 3336176. https://pubmed.ncbi.nlm.nih.gov/3336176/4. Weinstein GD, Nigra TP, Pochi PE, et al. Topical tretinoin for treatment of photodamaged skin: a multicenter study. Arch Dermatol. 1991;127(5):659-665. PMID 2024983. https://pubmed.ncbi.nlm.nih.gov/2024983/5. Kafi R, Kwak HS, Schumacher WE, et al. Improvement of naturally aged skin with vitamin A (retinol). Arch Dermatol. 2007;143(5):606-612. https://doi.org/10.1001/archderm.143.5.6066. Kong R, Cui Y, Fisher GJ, et al. A comparative study of the effects of retinol and retinoic acid on histological, molecular, and clinical properties of human skin. J Cosmet Dermatol. 2016;15(1):49-57. https://doi.org/10.1111/jocd.121937. Creidi P, Vienne MP, Ochonisky S, et al. Profilometric evaluation of photodamage after topical retinaldehyde and retinoic acid treatment. J Am Acad Dermatol. 1998;39(6):960-965. https://doi.org/10.1016/s0190-9622(98)70270-18. Cunliffe WJ, Poncet M, Loesche C, Verschoore M. A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials. Br J Dermatol. 1998;139 Suppl 52:48-56. https://doi.org/10.1046/j.1365-2133.1998.1390s2048.x9. Thiboutot D, Gold MH, Jarratt MT, et al. Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris. Cutis. 2001;68(4 Suppl):10-19. PMID 11845943. https://pubmed.ncbi.nlm.nih.gov/11845943/10. Kang S, Goldfarb MT, Weiss JS, et al. Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: a randomized trial. J Am Acad Dermatol. 2003;49(1):83-90. https://doi.org/10.1067/mjd.2003.45111. Bagatin E, Goncalves HS, Sato M, Almeida LMC, Miot HA. Comparable efficacy of adapalene 0.3% gel and tretinoin 0.05% cream as treatment for cutaneous photoaging. Eur J Dermatol. 2018;28(3):343-350. https://doi.org/10.1684/ejd.2018.332012. Reynolds RV, Yeung H, Cheng CE, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024;90(5):1006.e1-1006.e30. https://doi.org/10.1016/j.jaad.2023.12.01713. Loureiro KD, Kao KK, Jones KL, et al. Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy. Am J Med Genet A. 2005;136(2):117-121. https://doi.org/10.1002/ajmg.a.3074414. US Food and Drug Administration. FDA approves Differin Gel 0.1% for over-the-counter use to treat acne (2016). https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm510362.htm15. Differin (adapalene gel 0.1%) OTC Drug Facts label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020380Orig1s011lbl.pdf16. Retin-A Micro (tretinoin gel) prescribing information, revised September 2025, section 8.1. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020475s029lbl.pdf17. US Food and Drug Administration. iPLEDGE REMS for isotretinoin. https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm094305.htm

  7. 4d ago

    Five Fights: What the Evidence Says About Aesthetics' Biggest Arguments

    Dr. Tom McCann and Nova, his AI co-host, take on five live arguments in aesthetic medicine and separate what is on the record from opinion: whether you can become resistant to toxin, why hyaluronic acid filler keeps turning up on MRI years later, the regulatory status of exosomes, polynucleotides and Lemon Bottle, the fight over mandatory ultrasound for the Brazilian butt lift, and a lightning round on self-injected toxin, peptides, compounded semaglutide and med spa oversight. Key facts. Allergan/AbbVie pooled analysis of 33 trials (Toxins 2023): neutralizing antibodies in 3 of 810 glabellar subjects, 0 of 915 crow's feet subjects, 27 of 5,876 overall. JAAD International 2024: 15 patients with complete cosmetic resistance; 2 of 15 responded to another type A toxin, 6 of 7 to rimabotulinumtoxinB. UK patient survey (n = 919): 2.9% self-reported resistance. PRS Global Open 2024: HA present on MRI in all 33 patients at least 2 years after last midface injection. FDA: "There are currently no FDA-approved exosome products." Swissmedic, March 26, 2024: Lemon Bottle classified as an illegal medicinal product. Florida HB 1471 (2023), and a more than 80% fall in BBL fat embolism deaths in Miami-Dade as reported by Pazmiño (no data published); 6,235 ultrasound-guided patients with no reported deaths or fat embolism. MMWR, November 27, 2025: three women hospitalized after self-injecting toxin bought online. FDA, as of May 31, 2026: 990 adverse event reports for compounded semaglutide and more than 730 for compounded tirzepatide. MMWR, April 25, 2024: five HIV infections linked to an unlicensed New Mexico spa. For clinicians: courses, the Complication and Emergency Protocol Pack, and imaging teaching at mccannmd.com. For patients: book a consult through the Artemis Modern Aesthetics website. Join the waitlist for the aesthetic ultrasound injector course: https://artemis-modern-aesthetics.kit.com/dae19ec596 The voices in this episode were generated with AI using ElevenLabs. Tom reviews every script. This episode is education, not medical advice for any individual. References1. Pooled immunogenicity analysis of onabotulinumtoxinA across 33 clinical trials (AbbVie authors). Toxins, 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10224273/2. Case series of complete cosmetic botulinum toxin resistance, 15 patients at 12 sites. JAAD International, 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11564985/3. Review of botulinum toxin immunoresistance in aesthetic practice. JMIR Dermatology, April 2025. https://derma.jmir.org/2025/1/e699604. Meta-analysis of neutralizing antibodies across botulinum toxin formulations in therapeutic indications. European Journal of Neurology, July 2025. https://onlinelibrary.wiley.com/doi/full/10.1111/ene.702895. UK survey of 919 cosmetic botulinum toxin patients. Aesthetic Surgery Journal Open Forum, September 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12578598/6. MRI of midface HA filler persistence in 33 patients. Plastic and Reconstructive Surgery Global Open, July 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11250456/7. Quantitative 3D MRI of HA filler volume in 14 patients. Plastic and Reconstructive Surgery Global Open, July 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC13327366/8. Bertucci et al. Patient Misconceptions About Hyaluronic Acid Fillers: Experience-Based Considerations. Aesthetic Surgery Journal, July 10, 2026 (Allergan Aesthetics co-author). https://academic.oup.com/asj/advance-article/doi/10.1093/asj/sjag144/87296149. Galderma Restylane migration study, MRI and ultrasound at 12 and 24 weeks. ClinicalTrials.gov NCT07079397. https://clinicaltrials.gov/study/NCT0707939710. US Food and Drug Administration. Public Safety Notification on Exosome Products, December 6, 2019. https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/public-safety-notification-exosome-products11. Review of exosomes in dermatology and aesthetics. Dermatological Reviews, April 2026. https://onlinelibrary.wiley.com/doi/10.1002/der2.7007112. Refulgo. Are PDRNs the next magic ingredient? (summary of the 2026 systematic review of 7 RCTs). https://refulgo.com/are-pdrns-the-next-magic-ingredient-from-cosmetic-hype13. arznei-telegramm. Fat-dissolving injection Lemon Bottle (Swissmedic action, March 26, 2024). https://www.arznei-telegramm.com/en/272/fat-dissolving-injection-lemon-bottle-and-food-supplements-for-weight-loss14. IMCAS. Navigating hype products (Lemon Bottle social reach and UK status). https://www.imcas.com/en/blog/article/1055/navigating-hype-products15. Mofid MZ et al. Report on mortality from gluteal fat grafting: ASERF task force. Aesthetic Surgery Journal, 2017. https://pubmed.ncbi.nlm.nih.gov/28369293/16. Garcia O Jr, Pazmiño P. Pulmonary fat embolism deaths after gluteal fat grafting in South Florida, 2010 to 2022. Aesthetic Surgery Journal, 2022. doi:10.1093/asj/sjac224. https://pmc.ncbi.nlm.nih.gov/articles/PMC9896146/17. Pazmiño P. Commentary on ultrasound-guided gluteal fat grafting and Florida HB 1471. Aesthetic Surgery Journal 2026;46(1):63-64 (online November 1, 2025). https://academic.oup.com/asj/article/46/1/63/830769618. Finkelstein ER et al. Survey of BBL surgeons on ultrasound use and mandates. Aesthetic Surgery Journal 2024;44(1):NP69. doi:10.1093/asj/sjad310. https://academic.oup.com/asj/article/44/1/NP69/727943619. Centers for Disease Control and Prevention. Fungal meningitis outbreak associated with procedures performed under epidural anesthesia in Matamoros, Mexico. https://archive.cdc.gov/www_cdc_gov/hai/outbreaks/meningitis-epidural-anesthesia.html20. The Telegraph. Botched surgery abroad costs NHS 20k a patient, January 13, 2026. https://www.telegraph.co.uk/news/2026/01/13/botched-surgery-abroad-costs-nhs-20k-a-patient21. Botulism after self-injection of botulinum toxin purchased online. MMWR, November 27, 2025. https://www.cdc.gov/mmwr/volumes/74/wr/mm7438a1.htm22. New York City Health Department. Health Advisory on DIY botulinum toxin injection, December 1, 2025. https://www.nyc.gov/assets/doh/downloads/pdf/han/advisory/2025/han-advisory-26-diy-botox.pdf23. US Food and Drug Administration. FDA warns companies over illegal marketing of Botox and related products, November 2025. https://www.fda.gov/news-events/press-announcements/fda-warns-companies-over-illegal-marketing-botox-and-related-products24. Holland and Knight. HHS issues interim enforcement discretion policy for compounding of certain peptides, November 4, 2026. https://www.hklaw.com/en/insights/publications/2026/11/hhs-issues-interim-enforcement-discretion-policy-for-compounding25. AP via PBS NewsHour. FDA scientists opposed the move to ease peptide access, October 28, 2026. https://www.pbs.org/newshour/health/ap-report-fda-scientists-opposed-the-trump-administrations-move-to-ease-peptides-access26. US Court of Appeals for the Fifth Circuit. Outsourcing Facilities Association v. FDA, No. 25-10758, filed August 27, 2026. https://www.govinfo.gov/content/pkg/USCOURTS-ca5-25-10758/pdf/USCOURTS-ca5-25-10758-0.pdf27. US Food and Drug Administration. FDA's concerns with unapproved GLP-1 drugs used for weight loss (updated October 1, 2026). https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss28. HIV transmission associated with cosmetic PRP microneedling at an unlicensed spa, New Mexico. MMWR, April 25, 2024. https://www.cdc.gov/mmwr/volumes/73/wr/mm7316a3.htm29. American Society for Dermatologic Surgery Association. Lack of physician supervision in medical spas (Las Vegas study, Dermatologic Surgery, October 2024), January 8, 2025. https://www.asds.net/skin-experts/news-room/press-releases/asdsa-finds-lack-of-physician-supervision-in-medical-spas30. American Med Spa Association. Med spa statistics. https://www.amer...

  8. Nov 7

    The Collagen Cliff: Menopause and Your Skin

    Skin often changes fast around menopause. Dr. Tom McCann and Nova, his AI co-host, explain how falling estrogen affects collagen, what randomized trials of hormone therapy found for skin, what the small studies of estrogen creams on the face show, how the November 2025 FDA labeling change fits in, and which treatments have the strongest evidence. Key facts. Brincat's group measured a skin collagen decline of about 1 to 2 percent a year after menopause (Obstet Gynecol 1987). In KEEPS, four years of oral or transdermal estrogen did not improve wrinkles or skin rigidity versus placebo (Owen 2016). Topical estradiol for two weeks raised collagen in sun-protected skin but not in photoaged facial skin (Rittié 2008). No estrogen product is FDA approved for facial skin. NASEM (2020) found insufficient evidence for the clinical utility of compounded bioidentical hormones. FDA requested removal of several boxed warnings from menopausal hormone therapy in November 2025; first updated labels approved February 2026. Book a consult: artemisnj.com Coming January 12, 2027: Imaging the Filler Complication, Dr. McCann's online course on reading filler on ultrasound, MRI and CT. Join the waitlist for the founding price: https://claude.ai/artifact/KNPp4Wn1wLPz4YdmaDoS1o References Brincat M, et al. Skin collagen after menopause. Obstet Gynecol. 1987;70(6):840-845. PMID 3120067.Calleja-Agius J, Muscat-Baron Y, Brincat MP. Skin ageing. Menopause Int. 2007;13(2):60-64. https://doi.org/10.1258/175404507780796325Guyuron B, Rowe DJ, Weinfeld AB, et al. Factors contributing to the facial aging of identical twins. Plast Reconstr Surg. 2009;123(4):1321-1331. https://doi.org/10.1097/PRS.0b013e31819c4d42Owen CM, et al. KEEPS ancillary skin study, four-year results. Fertil Steril. 2016;106(5):1170-1175.e3. https://doi.org/10.1016/j.fertnstert.2016.06.023Phillips TJ, Symons J, Menon S; HT Study Group. Randomized placebo-controlled trial of low-dose norethindrone acetate and ethinyl estradiol for age-related skin changes. J Am Acad Dermatol. 2008;59(3):397-404. https://doi.org/10.1016/j.jaad.2008.05.009Schmidt JB, Binder M, Demschik G, Bieglmayer C, Reiner A. Treatment of skin aging with topical estrogens. Int J Dermatol. 1996;35(9):669-674. https://doi.org/10.1111/j.1365-4362.1996.tb03701.xRittié L, Kang S, Voorhees JJ, Fisher GJ. Induction of collagen by estradiol: difference between sun-protected and photodamaged human skin in vivo. Arch Dermatol. 2008;144(9):1129-1140. https://doi.org/10.1001/archderm.144.9.1129Yoon HS, Lee SR, Chung JH. Long-term topical estrogen on sun-exposed facial skin in postmenopausal women. Acta Derm Venereol. 2014;94(1):4-8. PMID 23722352.Wentworth AB. Menopause and skin. Menopause. 2026;33:1031-1033. https://doi.org/10.1097/GME.0000000000002889National Academies of Sciences, Engineering, and Medicine. The Clinical Utility of Compounded Bioidentical Hormone Therapy. 2020. https://www.nationalacademies.org/read/25791/chapter/11US HHS. Fact sheet: FDA initiates removal of black box warnings from menopausal hormone replacement therapy products. November 10, 2025. https://www.hhs.gov/press-room/fact-sheet-fda-initiates-removal-of-black-box-warnings-from-menopausal-hormone-replacement-therapy-products.htmlUS FDA. FDA approves labeling changes for menopausal hormone therapy products. February 12, 2026. https://www.fda.gov/news-events/press-announcements/fda-approves-labeling-changes-menopausal-hormone-therapy-productsGriffiths CE, Russman AN, Majmudar G, Singer RS, Hamilton TA, Voorhees JJ. Restoration of collagen formation in photodamaged human skin by tretinoin (retinoic acid). N Engl J Med. 1993;329(8):530-535. https://doi.org/10.1056/NEJM199308193290803Renova (tretinoin cream) 0.02% prescribing information, indications and limitations of use.

About

A radiologist who injects walks through aesthetic medicine with the evidence. Dr. Tom McCann, a board-certified radiologist and the physician at Artemis Modern Aesthetics in Medford, New Jersey, and Alexandra cover neuromodulators, fillers, GLP-1 medicines, skin science and devices, one primary source at a time. The voices in this show are generated with AI using ElevenLabs. Tom writes and reviews every script, and the sources are in the show notes.